Primary Site >> Stomach Cancer

Gene >> EIF3A

  • 1992
  • 1994
  • 1995
  • 1997
  • 2000
  • 2001
  • 2002
  • 2003
  • 2005
  • 2016
  • 2017
Ref: Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
PMID: 1352299
Ref: [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
PMID: 7912666
Ref: Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.
PMID: 7562911
Ref: erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
PMID: 7562912
Ref: [Expression of ras and erbB2 in benign and malignant lesions of the stomach].
PMID: 8697969
Ref: Immunoselective cell growth inhibition by antibody-adriamycin conjugates targeting c-erbB-2 product on human cancer cells.
PMID: 8845823
Ref: Expression of the c-erbB-2 proto-oncogene product in gastric carcinoma and precancerous lesions.
PMID: 27041970
Ref: c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
PMID: 10829039
Ref: Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7.
PMID: 11169732
Ref: Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.
PMID: 11948459
Ref: Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma.
PMID: 12439914
Ref: The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
PMID: 26680923
Ref: Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
PMID: 16457151
Ref: Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer.
PMID: 27333287
Ref: High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.
PMID: 29123423